KinATLAS
TranscriptoNET
PhosphoNET
OncoNET
KinaseNET
DrugKiNET
KiNET-AM
Kinetica Online
Search by protein name, UniProt number, IPI number, or 15 AA P-site sequence.
Updated: 2017 Aug. 1
|
Home
|
Kinexus
|
Contact
|
Credits
Note
- Blast analyses are based on comparisons of the phosphosites and the bordering four amino acids on each side of these phosphosites.
Phosphosite
Human Protein:
HSPG2
Human P-Site:
Y1802
P-Site Sequence:
AKSKSPA
Y
TLVWTRL
UniProt:
P98160
Intern. Prot. ID:
IPI00024284
Protein Phosphosite
Match
Human Protein
Short Name
Human
UniProt. ID
Phosphosite
Number
Sequence
% Identity / # AA
Target Size kDa
Phosphosite 0:
HSPG2
P98160
Y1802
AKSKSPAYTLVWTRL
100 / 9 AA
469
Phosphosite 1:
HSPG2
P98160
T1803
KSKSPAYTLVWTRLH
100 / 8 AA
469
Phosphosite 2:
JAG1
P78504
Y1176
RFAKQPAYTLVDREE
87 / 8 AA
134
Phosphosite 3:
ODF3L2
Q3SX64
S71
RVASPAYSLVRRPSE
75 / 8 AA
31
Phosphosite 4:
ODF3L2
Q3SX64
Y70
TRVASPAYSLVRRPS
75 / 8 AA
31
Phosphosite 5:
ODF3L1
Q8IXM7
Y67
SMFKAPAYTLHSRHS
66 / 9 AA
31
Phosphosite 6:
LMNB2
Q03252
T525
VAHSPPSTLVWKGQS
75 / 8 AA
68
Phosphosite 7:
LMNB2
Q03252
S524
GVAHSPPSTLVWKGQ
75 / 8 AA
68
Phosphosite 8:
JAG1
P78504
T1177
FAKQPAYTLVDREEK
100 / 6 AA
134
Phosphosite 9:
Putative lipoyltransferase 2, mitochondrial
A6NK58
Y142
ARARPPPYTGVWLDD
55 / 9 AA
25
Phosphosite 10:
MED1
Q15648
S1453
GSPSHSKSPAYTPQN
100 / 6 AA
168
Phosphosite 11:
MED1
Q15648
Y1456
SHSKSPAYTPQNLDS
100 / 6 AA
168
Phosphosite 12:
TIMM50
Q3ZCQ8
T149
PYYQPPYTLVLELTG
71 / 7 AA
40
Phosphosite 13:
4930429A22Rik Probable exonuclease
Q8IYB7
T817
VGKKPELTLVWEPED
71 / 7 AA
99
Phosphosite 14:
SGK223
Q86YV5
Y159
NSRCPPAYTMVGLHN
71 / 7 AA
150
Phosphosite 15:
NEK8
Q86SG6
Y161
LSSKSKAYTVVGTPC
75 / 8 AA
75
Phosphosite 16:
SGK223
Q86YV5
T160
SRCPPAYTMVGLHNL
71 / 7 AA
150
Phosphosite 17:
LCHN
A4D1U4
T162
GILSPSYTLLYRYMH
62 / 8 AA
51
Phosphosite 18:
TIMM50
Q3ZCQ8
Y148
EPYYQPPYTLVLELT
71 / 7 AA
40
Phosphosite 19:
Putative lipoyltransferase 2, mitochondrial
A6NK58
T143
RARPPPYTGVWLDDR
62 / 8 AA
25
Phosphosite 20:
COL7A1
Q02388
Y2888
DEGSCTAYTLRWYHR
62 / 8 AA
295